Jefferies Financial Group Inc. (JEF): what the price assumes

In the published model solve dated 2026-Q2, anchored at $54.64, Jefferies Financial Group Inc. (JEF) is priced for +9.6% earnings growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-07-29 · Exported: 2026-08-01 · Source: https://boothcheck.com/report/JEF

Headline

FieldValue
TickerJEF
CompanyJefferies Financial Group Inc.
Current price$54.64/sh
CompositionInvestment Banking and Capital Markets 90% / Asset Management 10%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basisfee-financial
Implied earnings growth9.6%
Price-to-earnings16.6x
Earnings yield6.0%

Solve inputs: computed at a 11.9% cost of equity with 4% terminal growth over a 5-year stage, on a 5-year median GAAP earnings base; each 1pp of cost of equity moves the implied earnings growth ~3.2pp.

Reconcile: at the x-ray's 9.3% required return this reads ~0%/yr; the models below use their own rates.

How unusual the bet is: within-range

ReferenceValue
vs own history-0.30σ
cohort percentile (of 51 peers)26
implied end-window share0%

Valuation X-Ray

The price is supported by asset-based and relative-multiple and growth-DCF value, while earnings-power lands below the price. A value/asset-supported name, not a pure growth bet.

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset1.24x4expensive
Earnings1.97x1expensive
Relative0.63x2justifies
Growth0.76x3justifies

Families that justify the price: Asset, Relative, Growth Families that call it expensive: Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.0%); the inversion above states its own rate.

Per-Model Detail (n=10)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$0.00—noNegative/zero FCF — equity value floored at $0
DCF Exit MultipleGrowth$0.00—noNegative/zero FCF or EBITDA — equity value floored at $0
Relative ValuationRelative$57.840.94xyesP/E 12x (static sector reference · 2026-04), scenarios: 9.9x / 12.0x / 14.1x (bear / base = reference held flat / bull), EV/EBITDA N/Ax
Simple DDMGrowth$179.600.30xyesDPS $1.80, g=8.2% (sustainable: ROE (TTM) × retention; not the terminal-growth assumption), ke=9.3%
Two-Stage DDMGrowth$15.113.62xyesStage 1: -13% for 5yr, Stage 2: 3.5% perpetual
Simple Excess ReturnAsset$45.641.20xyesBV/sh $51.69, ROE (TTM) 8.2%, ke 9.3%
Two-Stage Excess ReturnAsset$42.861.27xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$71.930.76xyesRev $11.8B, growth 14% (input: historical growth; tapered), Terminal P/S: 0.8x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 12x)
Growth-Adjusted P/ERelative——no—
Margin TrajectoryGrowth——no—
Earnings Power ValueEarnings——no—
Residual IncomeAsset$42.411.29xyesBV $51.69 + 5yr PV of (ROE (TTM) 8.2% − Kₑ 9.3%) × BV; BV grows 5.3%/yr
Graham NumberAsset$54.561.00xyes√(22.5 × EPS $2.56 × BVPS $51.69) — Graham's conservative floor
EV/EBITDA RelativeRelative——no—
FCF YieldEarnings——no—
SBC-Adj FCF YieldEarnings——no—
Ben Graham FormulaEarnings$2.1525.41xyesEPS $2.56 × (8.5 + 2×-5.0%) × (4.4 / 5.3%) (excluded from median)
ROIC-Justified P/BAsset——no—
P/Sales SectorRelative$173.840.31xyesRevenue $11.85B × sector P/S 3.0x
PEG Fair ValueRelative——no—
Earnings YieldEarnings$27.681.97xyesEPS $2.56 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelative——no—
Clinical Phase NPVGrowth——no—
MertonAsset——no—
V5 Mechanical———no—

Solvency

FieldValue
Share count CAGR (buyback)-4.3%

Corporate solvency inputs do not resolve from the filings for this fee business (operating income or debt concepts are untagged), so net-debt and coverage lenses are suppressed rather than rendered from artifacts. Share-count CAGR is kept.

Bullet Takeaways

Bull Case

Start with the bear's central objection, because Jefferies' defenders have to answer it head-on: investment banking is brutally cyclical, and paying a premium for a bank at the top of a deal cycle is how investors get hurt. The objection is fair, and the second quarter was unmistakably a strong-cycle quarter, with investment-banking revenue up 57%. But the data underneath the cyclical headline shows a franchise that has been gaining share through the cycle, not just riding it. Jefferies has spent years hiring senior bankers and building advisory and capital-markets capabilities while larger rivals retrenched, and the payoff is a quarterly record in investment banking and record equities revenue of $601 million. A firm setting records is taking wallet share, which is structural, not merely cyclical.

The second-quarter breadth supports the share-gain reading over a pure-cycle one. Investment banking led at $1.21 billion, but capital markets rose 14% to $799 million, equities set a record, and fixed income grew 12%, so the strength was diversified across the franchise rather than concentrated in one hot product. The 10-K is candid that the firm's edge depends on its people, warning that competitive pressure for "revenue producing roles" could hurt the business, which is the flip side of a strategy that has successfully attracted senior talent. A return on adjusted tangible equity of 12.8% in the quarter shows the expanded platform is earning real returns, not just booking revenue.

The capital story rounds out the case. Jefferies pays a $0.40 quarterly dividend, repurchased 4 million shares for $197 million in the quarter, and has been shrinking its share count more than 4% a year, returning capital aggressively while still investing in growth, including the planned acquisition of a stake in Hildene to build out asset management. The valuation methods are not uniformly stretched: the simple dividend model lands near the price and relative valuation modestly above it, so the price is not divorced from the fundamentals. The bull case is that the cyclical risk is real but the franchise has structurally improved, gaining share and diversifying, and at a price the dividend and relative methods can roughly support, the market is getting a better bank than the one it is pricing.

Bear Case

The most fragile assumption in the Jefferies price is that the current deal environment, not a normalized one, is the right basis for valuing the firm. At $62.11 the price needs the elevated investment-banking and capital-markets revenue to persist, and that revenue is the most cyclical line in finance. The second quarter's 57% jump in investment banking is wonderful, but it is a peak-cycle figure; deal volumes collapse in downturns, and when they do, the revenue that is carrying the valuation evaporates fastest. The 10-K spells out the mechanism, warning that "a market downturn, potential recession and high inflation, as well as declines in consumer confidence and an increase in unemployment rates, could lead to a decline in the volume of transactions." The whole thesis rests on a transaction environment that history says is temporary.

The valuation methods confirm the price leans on the optimistic end. The asset, earnings-power, and peer-multiple families all land below the price: the excess-return and residual-income methods in the high twenties to mid-thirties, and the earnings-power value is not even meaningful because the trailing operating result is near zero on a GAAP basis. Only the growth-DCF reaches the price, and it does so by extrapolating the strong recent results forward. The framework flags the name as a durability bet that the static frames cannot support. For a business whose earnings are this volatile, paying a price that requires the good times to continue is the textbook way to overpay at a cycle peak.

The structural realities make the cyclicality harder to underwrite. Jefferies runs a large balance sheet, with about $19 billion of gross debt funding its trading and inventory positions, and a market dislocation can turn that leverage from a return engine into a risk overnight. The firm competes against far larger, better-capitalized banks for both deals and talent, and its results depend on retaining the senior bankers it spent years recruiting, a cost that rises when rivals compete for the same people. Asset-management revenue, the steadier line, actually fell year over year in the quarter as the firm reallocates capital. The bear case is that the price embeds a continuation of an exceptional deal cycle, on top of a leveraged balance sheet and a talent-dependent model, and the single most fragile assumption, that peak-cycle banking revenue is the new normal, is the one most likely to break.

Valuation

Jefferies has to be valued as a fee financial whose earnings are cyclical and whose GAAP operating line is distorted by the way a broker-dealer reports. At $62.11 the asset, earnings-power, and peer-multiple methods all say richly valued: the excess-return and residual-income methods land in the high twenties to mid-thirties, relative valuation near $49, and the earnings-power value is not meaningful because the trailing operating figure is near zero on a GAAP basis. The simple dividend model lands near the price at $68, and only the growth-DCF clearly reaches it, so the framework reads the price as a durability bet the static frames cannot support. The blended figure across the methods is near $35, well below the price.

The valuation hinges entirely on which point in the cycle you anchor to. On the second quarter's record investment-banking and capital-markets revenue, the price is defensible; on a normalized, through-cycle level of deal activity, it is rich. Because banking revenue is among the most volatile in finance, the honest framing is that the stock is fairly valued to expensive on normalized earnings and only cheap if the current cycle is the new baseline, which is the assumption the bears rightly challenge.

The balance sheet is the part that demands respect rather than alarm. Jefferies funds a large trading and inventory book with about $19 billion of gross debt, which is normal for a broker-dealer but makes the firm sensitive to market dislocations; the dividend and the aggressive buyback (share count down more than 4% a year) show management confidence and return capital well.

Catalysts

Jefferies' second quarter of 2026 was a deal-boom quarter that beat on nearly every line. Net revenues were $2.21 billion and net earnings to common shareholders $226 million, or $1.02 per diluted share, with investment-banking net revenues a quarterly record at $1.21 billion, up 57% year over year. Capital markets rose 14% to $799 million, equities set a record at $601 million, and fixed income grew 12%, lifting the return on adjusted tangible equity to 12.8%. The board declared a $0.40 quarterly dividend and repurchased 4 million shares for $197 million, and the firm is preparing to acquire half of Hildene to expand asset management.

The catalysts from here are dominated by the deal and trading cycle. The key things to watch are whether investment-banking activity, mergers, equity issuance, and debt underwriting, stays robust or cools as rate and macro conditions shift, the trajectory of the trading businesses, and the build-out of asset management through the Hildene transaction. Talent retention is a quiet but important signal, since the franchise depends on its senior bankers. Capital return through the dividend and continued buybacks is a steady support. The question that resolves the stock is whether the current strong deal environment persists long enough to justify a price that already reflects it, or whether the cycle reverts toward its long-run average and pulls the cyclical revenue, and the valuation, down with it.

Peer Cohorts (Per Segment, With Filing Citations)

Investment Banking and Capital Markets (reported)

Asset Management (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Jefferies Q2 2026 earnings, TradingView / StockTitan, 2026 · Jefferies Q2 2026 earnings, StockTitan, 2026 · Jefferies Q2 2026 earnings, TradingView, 2026

View the full interactive JEF report on boothcheck